Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

Dostępny od:

Hospira Australia Pty Ltd

INN (International Nazwa):

Vinorelbine tartrate

Forma farmaceutyczna:

Injection

Skład:

Excipient Ingredients: water for injections

Droga podania:

Intravenous

Sztuk w opakowaniu:

1 x 1 mL vial

Klasa:

Medicine Listed (Export Only)

Typ recepty:

Not scheduled. Not considered by committee

Wskazania:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

Podsumowanie produktu:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status autoryzacji:

Listed (Export Only)

Data autoryzacji:

2008-05-05